X
Please Wait
Applying Filters...
01 INSULIN DETEMIR RECOMBINANT (5)
01 NOVO NORDISK INC (5)
01 INJECTABLE;SUBCUTANEOUS (5)
01 1000 UNITS/10ML (100 UNITS/ML) (1)
02 300 UNITS/3ML (100 UNITS/ML) (4)
01 USA (5)
19
Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is INSULIN DETEMIR RECOMBINANT, with a corresponding application number 21536 and regulatory information .
proudly manufactured in the
Novo Nordisk's LEVEMIR INJECTABLE;SUBCUTANEOUS, medication with 1000 UNITS/10ML (100 UNITS/ML) of INSULIN DETEMIR RECOMBINANT.
18
Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is INSULIN DETEMIR RECOMBINANT, with a corresponding application number 21536 and regulatory information .
proudly manufactured in the
Novo Nordisk's LEVEMIR PENFILL INJECTABLE;SUBCUTANEOUS, medication with 300 UNITS/3ML (100 UNITS/ML) of INSULIN DETEMIR RECOMBINANT.
17
Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is INSULIN DETEMIR RECOMBINANT, with a corresponding application number 21536 and regulatory information .
proudly manufactured in the
Novo Nordisk's LEVEMIR FLEXPEN INJECTABLE;SUBCUTANEOUS, medication with 300 UNITS/3ML (100 UNITS/ML) of INSULIN DETEMIR RECOMBINANT.
16
Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is INSULIN DETEMIR RECOMBINANT, with a corresponding application number 21536 and regulatory information .
proudly manufactured in the
Novo Nordisk's LEVEMIR FLEXTOUCH INJECTABLE;SUBCUTANEOUS, medication with 300 UNITS/3ML (100 UNITS/ML) of INSULIN DETEMIR RECOMBINANT.
15
Novo Nordisk, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is INSULIN DETEMIR RECOMBINANT, with a corresponding application number 21536 and regulatory information .
proudly manufactured in the
Novo Nordisk's LEVEMIR INNOLET INJECTABLE;SUBCUTANEOUS, medication with 300 UNITS/3ML (100 UNITS/ML) of INSULIN DETEMIR RECOMBINANT.
Market Place
